Position in GMAB
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$120,208
-$19,308 QoQ
Shares Held
4,376
-15.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#177
of 288 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD PRIVATE CLIENT WEALTH LLC holds $2,695,967 across 45 Biotechnology names. GMAB ranks #4 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,440 | $731,270 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
2,863 | $689,897 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,361 | $676,049 | |
| 4 | GMAB |
Genmab A/S
This page
|
4,376 | $120,208 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
150 | $93,531 | |
| 6 | MRNA |
Moderna, Inc.
|
1,305 | $91,389 | |
| 7 | INSM |
INSMED Inc
|
517 | $55,122 | |
| 8 | ARGX |
Argenx SE
|
28 | $25,977 |
All Filings in GMAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,208 | 4,376 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $139,516 | 5,200 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $257,488 | 8,360 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $229,012 | 7,467 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $130,323 | 6,308 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $157,951 | 8,067 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $241,006 | 11,548 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $288,074 | 11,816 | Shares | Defined | 2024-11-18 | |
| 2024-06-30 | $348,151 | 13,854 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $412,249 | 13,783 | Shares | Defined | 2024-08-16 | |
| 2023-12-31 | $403,826 | 12,683 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $174,445 | 4,946 | Shares | Defined | 2024-08-16 | |
| 2023-06-30 | $84,686 | 2,228 | Shares | Defined | 2024-08-16 | |
| 2023-03-31 | $70,535 | 1,868 | Shares | Defined | 2024-08-16 | |
| 2022-12-31 | $237,158 | 5,596 | Shares | Defined | 2024-08-16 | |
| 2022-09-30 | $169,485 | 5,275 | Shares | Defined | 2024-08-16 | |
| 2022-06-30 | $35,803 | 1,102 | Shares | Defined | 2024-08-16 | |
| 2022-03-31 | $151,666 | 4,192 | Shares | Defined | 2024-08-16 | |
| 2021-12-31 | $120,697 | 3,051 | Shares | Defined | 2024-08-16 | |
| 2021-09-30 | $96,052 | 2,198 | Shares | Defined | 2024-08-16 | |
| 2021-06-30 | $84,273 | 2,064 | Shares | Defined | 2024-08-16 | |
| 2021-03-31 | $20,551 | 626 | Shares | Defined | 2024-08-16 | |
| 2020-12-31 | $24,761 | 609 | Shares | Defined | 2024-08-16 | |
| 2020-09-30 | $35,511 | 970 | Shares | Defined | 2024-08-16 | |
| 2020-06-30 | $440 | 13 | Shares | Defined | 2024-08-16 | |
| 2020-03-31 | $65,180 | 3,076 | Shares | Defined | 2024-08-16 | |
| No filing history on record for this holder in this stock. | ||||||